Cerebral Therapeutics
  • Company Background Board of Directors Company Management and Advisers
  • Refractory Epilepsy Background Neurologic Disease Burden Solution
  • News and Events
  • Investors
  • Contact Us
Cerebral Therapeutics
  • About Cerebral Therapeutics/
    • Company Background
    • Board of Directors
    • Company Management and Advisers
  • Burden of Neurologic Disease/
    • Refractory Epilepsy Background
    • Neurologic Disease Burden
    • Solution
  • News and Events/
  • Investors/
  • Contact Us/
scan-4.jpg
Cerebral Therapeutics

News and Events

Cerebral Therapeutics
  • About Cerebral Therapeutics/
    • Company Background
    • Board of Directors
    • Company Management and Advisers
  • Burden of Neurologic Disease/
    • Refractory Epilepsy Background
    • Neurologic Disease Burden
    • Solution
  • News and Events/
  • Investors/
  • Contact Us/
June 20, 2018

Cerebral Therapeutics Raises Series A Financing to Advance Clinical-Stage Drug-Device Combination Therapy for Adult Refractory Epilepsy

June 20, 2018/ Distill

Financing Led by Granite Point Capital and Vivo Capital
Cerebral Therapeutics Adds Three New Members to its Board of Directors

Aurora, CO., June 20, 2018

Read Full Article

June 20, 2018/ Distill/ Comment

Distill

  • News and Events
  • Flowonix Medical and Cerebral ...

© 2015 Cerebral Therapeutics, LLC. All rights reserved. Website by Creation Chamber.